Forensic Analysis · Technology / Software · as of Sep 6, 2026
Microvision, Inc. (MVIS)
A forensic read on Microvision, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
F · Poor — capital at risk
Forensic grade
Distress
Financial health
-2.6
Distress distance
Clean
Earnings quality
4
Forensic signals
-0.8
P / E (ttm)
-171.0%
ROE
$1.3B
Market cap
0.00%
Dividend yield
-74.3%
Revenue growth
This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (red flags, auditor quality, say on pay, board independence, valuation). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.
Microvision, Inc. earns an F (Poor — capital at risk) forensic quality grade, and its balance-sheet distress test reads -2.6, placing it in the Distress zone. 4 forensic signals were flagged in its latest SEC filings, led by accruals ratio (% of noa).
What the filings flag
+43.4%
FY2024→FY2025
Accruals ratio (% of NOA).Net operating assets grew +43.4% relative to their own average in FY2025 — scaled by NOA itself, not by total assets, which is what the Forensic Screens card's own accrual row divides by. Accruals are building sharply — a large slice of profit sits in operating assets, not cash. An accrual is a claim that still has to be collected or written down, so the gap resolves in a later period whichever way it goes. A cash-flow measure on the same base disagrees: reported earnings ran behind operating cash by 104% of net operating assets, against an accruals ratio of 43.4%. The two are computed differently: the accruals ratio is the change in net operating assets over average net operating assets, while the cash-flow figure is net income less operating cash flow over that same average. Read them as two results, not one.
+18.1%/yr
FY2022–FY2025
Share-count dilution.Diluted share count changed +65% over the last 3 years to FY2025 (+18.1%/yr). The count is growing: more stock was issued than repurchased over this window, so aggregate results grew faster than their per-share equivalents. That's ~18.1% shaved off per-share growth every year — total profit has to grow that much just to keep earnings-per-share flat, and a stake held since FY2022 has been diluted ~39%.
58% of rev
FY2025
Stock-based comp load.Stock-based compensation ran 58% of revenue in FY2025 — about $0.00 per diluted share. No cash left the business to pay it, which is why operating cash flow adds it back. Net of repurchases the diluted count still rose about 18.4% a year and that rate is not falling, so total profit has to grow by that much annually before any of it reaches a share. Stock compensation is one source of that issuance; acquisition consideration, equity raises, convertibles and other employee plans also net into the count, and these figures do not separate them.
Key fundamentals
Net Margin-7862.7%
Debt / Equity0.35x
Free Cash Flow-$59.4M
Latest Revenue$1.2M
Return on Equity-171.0%
Revenue Growth YoY-74.3%
The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Microvision, Inc.'s actual 10-K/10-Q/8-K filings?
Data from SEC EDGAR public filings · metrics as of Sep 6, 2026. Forensic signals flag probability, not certainty.
147d DSO
FY2024→FY2025
Receivables vs revenue.Days sales outstanding moved from 73 to 147 days FY2024→FY2025 (receivables -95% vs revenue -74%). Receivables are creeping up relative to sales.
Microvision, Inc. (MVIS) Stock — Forensic Analysis, Red Flags & Rating | Stockonomy · Stockonomy